References
- Balfour J. A., Buckley M-T. M. Drugs 1991; 42: 274–299
- Inoue K., Fujisawa H., Motonaga A., Inoue Y., Kyoi T., Ueda F., Kimura K. Biol. Pharm. Bull. 1994; 17: 1577–1583
- Puglisi G., Ventura C. A., Spadaro A., Campana G., Spampinato S. J. Pharm. Pharmacol. 1995; 47: 120–123
- Lin S. Z., Wouessidjewe D., Poelman M. C., Duchene D. Int. J. Pharm. 1991; 69: 211–219
- Cappello B., Barbato F., La Rotonda M. I., Miro A. (1995) “Proc. 1st World Meeting APGI/APV,”, Budapest, May, 9–111995, 589–590
- Higuchi T., Connors K. A. Phase solubility techniques. Adv. Anal. Chem. Instr. Interscience, New York 1965; 117–-212
- Merck Index, XI. Merck &, Co. Inc., New York 1993
- Guyot M., Fawaz F., Bildet J., Bonini F., Lagueny A. M. Int. J. Pharm. 1995; 123: 53–63
- Pena M. A., Tros de Ylarduya C., Martínez-Ohárriz C., Gõni M. M., Martín C., Sánchez M. (1995) “Proc. 1st World Meeting APGV/APV,”, Budapest, May, 9–111995, 597–598
- Yazan Y., Summi M. STP Pharm. Sci. 1994; 4: 128
- Rainsford K. D. Drug Invest. 1990; 2(Suppl. 4)3–10